Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹242.29
Market cap: ₹1,598 Cr
Revenue (annual): ₹287.2 Cr
Net profit (annual): ₹43.08 Cr
P/E (TTM): 35.1×Sector 50.4×
Promoter holding: 69.05%+1.16% QoQ
FII holding: 2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Financial Results 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Jul 2026 17:01 IST BSE

Financial Results

Jagsonpal Pharmaceuticals Q1 FY27 Results: Net Profit ₹13.2 Cr, Up 22.2% YoY

Jagsonpal Pharmaceuticals Ltd reported revenue from operations of ₹82.2 Cr (+8.7% YoY) and net profit of ₹13.2 Cr (+22.2% YoY) for Q1 FY27.

Key figure: Net profit ₹13.2 Cr · +22.2% YoY

Open full results → Read the filing ↗